Gossamer Bio Inc expected to post a loss of 77  cents a share - Earnings Preview

Gossamer Bio

02/05/2022 18:00

* Gossamer Bio Inc  GOSS.OQ   GOSS.O  is expected to show no
change in quarterly revenue when it reports  results on May 4
(estimated). 
    * ​Refinitiv's mean analyst estimate for Gossamer Bio Inc is
for a
loss of 77 cents per share. For the same quarter last year, the
company reported a loss of 78 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $15.5​, above​ its last closing price of $6.91. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.74       -0.74      -0.74     Met     0.4
 Sep. 30 2021  -0.78       -0.78      -0.80     Missed  -1.9
 Jun. 30 2021  -0.76       -0.76      -0.80     Missed  -5.6​
 Mar. 31 2021  -0.76       -0.75      -0.78     Missed  -3.7
 ​​Dec.        -0.82       -0.79      -0.88     Missed  -11.4
 31 2020                                                
 Sep. 30 2020  -0.87       -0.85      -0.80     Beat    6.3​
 Jun. 30 2020  -0.83       -0.86      -1.00     Missed  -15.8
 Mar. 31 2020  -0.79       -0.80      -0.87     Missed  -8.7
 This summary was machine generated May 2 at 17:00 GMT.  All
figures in US dollars  unless otherwise stated